6[6]Packer M. The development of positive inotropic agents for chronic heart failure: how have we gone astray?[M] .AM J cardiol, 1993,22: 119.
7Mizushima Y,yanagwa A, Hcshi K. Prostaglandin E1 is more effective,when incorporated in lipid micrespheres, for treatment of peripheral vascular disease in man. Jpharm pharmacol , 1983,35:666-667.
8Hesselink DA,Smak PJ ,Weimar W. The use of cyclos-porine in renal transplantation[J]. Transplatation Proc, 2004,36(1) : 328.
9Shishido S,Asanuma H, Nakai H, et al .The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy[J] .J- Am -Soc- Nephrol, 2003,14(4) : 1 046.
10Woo YC, Jong AH, Young KW, et al . Reconstruction for renal artery aneurysm: Operative techniques and long- term results[J] .Journal of Vascular Surgery,2003,37(2): 293.
